Yaoke Biotechnology: Plans to increase investment of 5 million yuan in Lingkang Biotechnology.

Yao Kang Biology announced that the company plans to use its own funds of 5 million yuan to subscribe to the newly increased registered capital of 892857 yuan for the affiliate company Ling Kang Biology. After the capital increase, the registered capital of Ling Kang Biology will increase from 15.001786 million yuan to 15.894643 million yuan, and the company's shareholding ratio will increase from 33.3413% to 37.0857%. This transaction constitutes a related party transaction, but does not constitute a major asset restructuring. The transaction has been approved at the relevant meetings and does not require shareholder approval. However, business registration changes still need to be processed, and the final approval time is uncertain.